We are live on ! Find out more
OMIC

Singular Genomics Systems, Inc. Common Stock
OMIC

Delisted

OMIC was delisted on the 20th of February, 2025.

Back to rankings

62 hedge funds and large institutions have $27.3M invested in Singular Genomics Systems, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more call options, than puts

Call options by funds: $27K | Put options by funds: $12K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 66 → 62 (-4)

21% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 19

24% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 21

38% less capital invested

Capital invested by funds: $43.8M → $27.3M (-$16.6M)

Holders
62
Holders Change
-4
Holders Change %
-6.06%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
16
Reduced
21
Closed
19
Calls
$27K
Puts
$12K
Net Calls
+$15K
Net Calls Change
-$24K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$840K
2
AI
Acuitas Investments
Washington
+$646K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$512K
4
Verition Fund Management
Verition Fund Management
Connecticut
+$469K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$201K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.54M
2
PA
Perceptive Advisors
New York
-$898K
3
State Street
State Street
Massachusetts
-$732K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$491K
5
EWA
EP Wealth Advisors
California
-$491K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$5.35M – – –
UBS Group
2
UBS Group
Switzerland
$3.88M -$17.7K -603 -0.4%
AVM
3
Arch Venture Management
Illinois
$3.15M – – –
PA
4
Perceptive Advisors
New York
$1.96M -$898K -30,635 -28%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$1.76M -$2.23K -76 -0.1%
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.57M -$226K -7,714 -11%
Coatue Management
7
Coatue Management
New York
$1.39M -$262K -8,937 -14%
CC
8
Casdin Capital
New York
$1.12M – – –
PIM
9
Platinum Investment Management
Australia
$731K – – –
BlackRock
10
BlackRock
New York
$725K -$2.54M -86,768 -75%
Millennium Management
11
Millennium Management
New York
$714K +$840K +28,657 New
AI
12
Acuitas Investments
Washington
$549K +$646K +22,063 New
Bank of Montreal
13
Bank of Montreal
Ontario, Canada
$461K +$512K +17,471 New
O
14
OrbiMed
New York
$449K – – –
Verition Fund Management
15
Verition Fund Management
Connecticut
$398K +$469K +16,000 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$349K -$491K -16,775 -55%
TM
17
Tikvah Management
North Carolina
$263K – – –
BCM
18
Bridgeway Capital Management
Texas
$230K +$51.9K +1,770 +24%
HighTower Advisors
19
HighTower Advisors
Illinois
$221K +$29.3K +1,000 +13%
Goldman Sachs
20
Goldman Sachs
New York
$183K +$144K +4,932 +203%
Jacobs Levy Equity Management
21
Jacobs Levy Equity Management
New Jersey
$171K +$201K +6,853 New
TM
22
Triatomic Management
California
$162K +$26.9K +917 +16%
YIH
23
Y-Intercept (HK)
Hong Kong
$128K +$150K +5,134 New
Squarepoint
24
Squarepoint
New York
$116K +$108K +3,702 +381%
State Street
25
State Street
Massachusetts
$116K -$732K -24,976 -84%
1
2 3 4

OMIC Hedge Fund Activity: Q2 2023 in Review

62 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q2 2023, worth a combined $27.3M — down 38% from $43.8M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of OMIC and 15 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 16 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $840K. The largest seller was BlackRock, cutting an estimated $2.54M.

  • 62 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q2 2023, down from 66 in Q1 2023.
  • Funds reported $27.3M of Singular Genomics Systems, Inc. Common Stock stock for Q2 2023, down 38% quarter-over-quarter.
  • 15 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q2 2023 and 19 closed out, a net change of -4 holders.
  • The largest Singular Genomics Systems, Inc. Common Stock buyer in Q2 2023 was Millennium Management, an estimated $840K added.
  • The largest Singular Genomics Systems, Inc. Common Stock seller in Q2 2023 was BlackRock, an estimated $2.54M sold.

Based on aggregated 13F filings for Q2 2023.